Abstract: Objective To analyze the survival time of HIV-infected/AIDS patients and its influencing factors in Jinjiang City from 2018 to 2022. Methods The case data of HIV-infected/AIDS patients in Jinjiang City from 2018 to 2022 were derived from the “AIDS Comprehensive Prevention and Control Data Information Management System” of China Disease Prevention and Control Information System, and the influencing factors of the survival time of HIV-infected/AIDS patients were analyzed using univariate and multivariate Cox proportional risk regression models. Results From 2018 to 2022, a total of 937 HIV-infected/AIDS patients with current addresses in Jinjiang City were registered, including 774 males and 163 females. At the end of observation, 151 of the 937 reported cases were AIDS-related deaths, the AIDS-related fatality rate was 16.12%, and the mean survival time was 154.55 months (95% CI: 138.20-170.90). Multivariate Cox proportional risk model results showed that baseline CD4+T lymphocytes were 200 - < 350/μL (HR=0.21, 95% CI: 0.10-0.43), ≥350 /μL (HR=0.18, 95% CI: 0.09 - 0.37), and antiviral therapy (ART) (HR=0.07, 95% CI: 0.04 - 0.13) had a lower risk of death. Conclusion Baseline CD4+T lymphocyte levels and ART are factors influencing survival in HIV-infected/AIDS patients.

Key words: HIV-infected/AIDS patients, Antiviral therapy, Survival time, Influencing factor